The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A. Voors, Piotr Ponikowski, Christiane E. Angermann et al.|Nature Medicine|2022Cited by 889
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D. Solomon, Subodh Verma, Johann Bauersachs et al.|New England Journal of Medicine|2024Cited by 693
Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetesGong Su, Changsheng Ma|Cardiovascular Diabetology|2011Cited by 257
Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF TrialScott D. Solomon, Dirk von Lewinski, John W. Ostrominski et al.|European Journal of Heart Failure|2024Cited by 62
Knockout of a novel salt responsive gene SlABIG1 enhance salinity tolerance in tomatoFei Ding, Ying Li, Qiang Xin et al.|Environmental and Experimental Botany|2022Cited by 44